当前位置: 首页 > 期刊 > 《中外医学研究》 > 2017年第9期
编号:13063357
环孢素A联合泼尼松治疗进展性IgA肾病的临床效果观察(3)
http://www.100md.com 2017年3月25日 中外医学研究 2017年第9期
     [3]陈灏珠.实用内科学[M].第11版.北京:人民卫生出版社,2003:1373-1378.

    [4] Zhang W X,Zhou W,Zhang Z Q,et al.Interstitial lung diseases after leflunomide use in nephropathy:an analysis of reported cases in Chinese literature[J].Nephrol Dial Transplant,2011,26(4):1416-1420.

    [5]蔡广研,陈香美.慢性肾脏病并发症治疗现状及思考[J].中国实用内科杂志,2010,22(2):102-103.

    [6]师素芳,张宏.对于IgA肾病牛津病理分析验证现状的分析[J].中华肾脏病杂志,2012,28(3):167-169.

    [7] Kidney Disease:Improving Global Outcomes(KDIGO) Glomerulonephritis Work Group.KDIGO Clinical Practice Guideline for Glomerulonephritis[J].Kidney Int Suppl,2012,2:139–274.

    [8] Cattran D C,Feehally J,Cook H T.Kidney Disease:Improving global outcomes(KDIGO) glomerulonephritis work group.KDIGO clinical practice guidline forglomerulonephritis[J].Kidney Int,2012,2(Suppl 2):139-274.

    [9] Pozzi C,Andrulli S,Del Vecchio L,et al.Glucocorticoid effectiveness in IgA nephropathy:long-tem results of a randomized,controled trial[J].J Am Soc Nephrol,2014,15(1):157-163.

    [10]郭齐,王荣.进展型IgA肾病的診断与治疗[J].临床肾脏病杂志,2009,9(7):298-300.

    [11] Zhou F D,Zhao M H,Zou W Z,et al.The changing spectrum of primary glomerular diseases within 15 years:a survey of 3331 patients in a single Chinese center[J].Nephrol Dial Transplant,2009,24(3):870-876.

    [12]列才华,谢院生.糖皮质激素治疗IgA肾病的循证研究[J].中国中西医结合肾病杂志,2008,9(3):274.

    (收稿日期:2016-11-07), 百拇医药(索斌诚)
上一页1 2 3